SCHEMBL26678178

SCHEMBL26678178

CN1CC2CC1CN2c1ccc(N)c(C2CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 11/20 0.37
▸ CHRNA7 P36544 11/20 0.37
▸ CHEK1 O14757 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ PRKCB P05771 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ LYN P07948 1/20 0.33
▸ MET P08581 1/20 0.33
▸ HCK P08631 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ BRAF P15056 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ PRKCA P17252 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ MAPKAPK2 P49137 1/20 0.33
▸ MAP4K2 Q12851 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33
▸ RPS6KA1 Q15418 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22652209 1.00 KCNH2 (0.37) KCNH2CHRNA7CHEK1ABL1PRKCB
SCHEMBL25557074 0.81 KCNH2 (0.40) KCNH2CHRNA7
SCHEMBL25556993 0.81 KCNH2 (0.40) KCNH2CHRNA7
SCHEMBL25236239 0.79 AKR1C3 (0.38) —
SCHEMBL25241300 0.79 AKR1C3 (0.38) —
SCHEMBL26677915 0.78 MAPT (0.38) KCNH2CHRNA7
SCHEMBL22652110 0.78 MAPT (0.38) KCNH2CHRNA7
SCHEMBL22652078 0.78 HSD11B1 (0.40) KCNH2CHRNA7
SCHEMBL22652003 0.78 HSD11B1 (0.40) KCNH2CHRNA7
SCHEMBL14180539 0.78 BRAF (0.41) KCNH2CHRNA7BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023215494-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF ERASCA, INC. (US) 2023-11-09 — — WO disclosed
EP-3966207-B1 PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS LLC (US) 2023-11-01 — — EP disclosed
Send feedback